{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:55:04Z","timestamp":1791186904450,"version":"4.1.0"},"reference-count":51,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,1]]},"abstract":"<jats:p>Roux-en-Y gastric bypass (RYGB) surgery is the most effective treatment for morbid obesity and remission of associated type 2 diabetes, but the mechanisms involved are poorly understood. The aim of the present study was to develop and validate a rat model for RYGB surgery that allows repeated measurement of meal-induced changes in gut and pancreatic hormones via chronic venous catheters. Male Sprague Dawley rats made obese on a palatable high-fat diet were subjected to RYGB or sham surgery and compared with chow-fed, lean controls. Hormonal responses to a mixed-liquid test meal were examined by frequent blood sampling through chronically implanted jugular catheters in freely behaving rats, 3\u20134 months after surgery, when RYGB rats had significantly reduced body weight and fat mass compared with sham-operated rats. Hyperleptinemia, basal hyperinsulinemia, and hyperglycemia as well as postprandial glucose intolerance seen in sham-operated, obese rats were completely reversed by RYGB and no longer different from lean controls. Postprandial increases in glucagon-like peptide-1, peptide YY, and amylin as well as suppression of ghrelin levels were all significantly augmented in RYGB rats compared with both sham-operated obese and lean control rats. Thus, our rat model replicates most of the salient hormonal and glycemic changes reported in obese patients after RYGB, with the addition of amylin to the list of potential candidate hormones involved in hypophagia, weight loss, and remission of diabetes. The model will be useful for elucidating the specific peripheral and central mechanisms involved in the suppression of appetite, loss of body weight, and remission of type 2 diabetes.<\/jats:p>","DOI":"10.1210\/en.2009-1332","type":"journal-article","created":{"date-parts":[[2010,2,24]],"date-time":"2010-02-24T03:18:55Z","timestamp":1266981535000},"page":"1588-1597","source":"Crossref","is-referenced-by-count":131,"title":["Meal-Induced Hormone Responses in a Rat Model of Roux-en-Y Gastric Bypass Surgery"],"prefix":"10.1210","volume":"151","author":[{"given":"Andrew C.","family":"Shin","sequence":"first","affiliation":[{"name":"Neurobiology of Nutrition Laboratory (A.C.S., H.Z., R.L.T., H.-R.B.), Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Neurobiology of Nutrition Laboratory (A.C.S., H.Z., R.L.T., H.-R.B.), Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Leigh","family":"Townsend","sequence":"additional","affiliation":[{"name":"Neurobiology of Nutrition Laboratory (A.C.S., H.Z., R.L.T., H.-R.B.), Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Sigalet","sequence":"additional","affiliation":[{"name":"Division of Pediatric General Surgery and the Gastrointestinal Research Group (D.L.S.), Faculty of Medicine, University of Calgary, Health Science Center, Calgary, Alberta, Canada T2N 4N1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Rudolf","family":"Berthoud","sequence":"additional","affiliation":[{"name":"Neurobiology of Nutrition Laboratory (A.C.S., H.Z., R.L.T., H.-R.B.), Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,2,23]]},"reference":[{"key":"2020071613462292900_R1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.sla.0000089851.41115.1b","article-title":"Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.","volume":"238","author":"Schauer","year":"2003","journal-title":"Ann Surg"},{"key":"2020071613462292900_R2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1381\/0960892053723402","article-title":"Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.","volume":"15","author":"Wickremesekera","year":"2005","journal-title":"Obes Surg"},{"key":"2020071613462292900_R3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.soard.2008.10.014","article-title":"Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass.","volume":"5","author":"Ali","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"2020071613462292900_R4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2004-1076","article-title":"Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.","volume":"90","author":"Korner","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613462292900_R5","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/oby.2006.179","article-title":"Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.","volume":"14","author":"Korner","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"2020071613462292900_R6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0b013e3180caa3e3","article-title":"Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.","volume":"246","author":"Roux","year":"2007","journal-title":"Ann Surg"},{"key":"2020071613462292900_R7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.sla.0000183349.16877.84","article-title":"Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.","volume":"243","author":"Roux","year":"2006","journal-title":"Ann Surg"},{"key":"2020071613462292900_R8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bjs.5227","article-title":"Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.","volume":"93","author":"Borg","year":"2006","journal-title":"Br J Surg"},{"key":"2020071613462292900_R9","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/jc.2005-0904","article-title":"Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.","volume":"91","author":"Mori\u0301nigo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613462292900_R10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/oby.2007.83","article-title":"Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.","volume":"16","author":"Rodieux","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"2020071613462292900_R11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.","volume":"346","author":"Cummings","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071613462292900_R12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1381\/096089204323093363","article-title":"The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus.","volume":"14","author":"Fru\u0308hbeck","year":"2004","journal-title":"Obes Surg"},{"key":"2020071613462292900_R13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/oby.2004.43","article-title":"Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.","volume":"12","author":"Stoeckli","year":"2004","journal-title":"Obes Res"},{"key":"2020071613462292900_R14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/SLA.0b013e3181904af0","article-title":"Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.","volume":"249","author":"Meirelles","year":"2009","journal-title":"Ann Surg"},{"key":"2020071613462292900_R15","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00153.2004","article-title":"Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats","volume":"288","author":"Strader","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613462292900_R16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.surg.2005.05.013","article-title":"Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.","volume":"138","author":"Suzuki","year":"2005","journal-title":"Surgery"},{"key":"2020071613462292900_R17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/SLA.0b013e318166fd5f","article-title":"Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function.","volume":"247","author":"Guijarro","year":"2008","journal-title":"Ann Surg"},{"key":"2020071613462292900_R18","doi-asserted-by":"crossref","first-page":"R1273","DOI":"10.1152\/ajpregu.00343.2009","article-title":"Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery","volume":"297","author":"Zheng","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071613462292900_R19","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/0016-5085(94)90831-1","article-title":"Glucagonlike peptide 1: a newly discovered gastrointestinal hormone.","volume":"107","author":"Holst","year":"1994","journal-title":"Gastroenterology"},{"key":"2020071613462292900_R20","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1210\/en.2008-0770","article-title":"Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.","volume":"149","author":"Trevaskis","year":"2008","journal-title":"Endocrinology"},{"key":"2020071613462292900_R21","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1210\/en.2007-0898","article-title":"Combination therapy with amylin and peptide YY[3\u201336] in obese rodents: anorexigenic synergy and weight loss additivity.","volume":"148","author":"Roth","year":"2007","journal-title":"Endocrinology"},{"key":"2020071613462292900_R22","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613462292900_R23","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/oby.2004.200","article-title":"Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry.","volume":"12","author":"Ku\u0308nnecke","year":"2004","journal-title":"Obes Res"},{"key":"2020071613462292900_R24","first-page":"E336","article-title":"Cephalic-phase insulin secretion in normal and pancreatic islet-transplanted rats","volume":"238","author":"Berthoud","year":"1980","journal-title":"Am J Physiol"},{"key":"2020071613462292900_R25","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1523\/JNEUROSCI.20-21-08122.2000","article-title":"Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward \u201cwanting\u201d without enhanced \u201cliking\u201d or response reinforcement.","volume":"20","author":"Wyvell","year":"2000","journal-title":"J Neurosci"},{"key":"2020071613462292900_R26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diacare.24.2.362","article-title":"Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.","volume":"24","author":"Katsuki","year":"2001","journal-title":"Diabetes Care"},{"key":"2020071613462292900_R27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.soard.2007.08.004","article-title":"Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.","volume":"3","author":"Korner","year":"2007","journal-title":"Surg Obes Relat Dis"},{"key":"2020071613462292900_R28","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jc.2007-2851","article-title":"Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.","volume":"93","author":"Laferre\u0300re","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613462292900_R29","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/dc06-1549","article-title":"Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes.","volume":"30","author":"Laferre\u0300re","year":"2007","journal-title":"Diabetes Care"},{"key":"2020071613462292900_R30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/diacare.22.7.1137","article-title":"Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.","volume":"22","author":"Toft-Nielsen","year":"1999","journal-title":"Diabetes Care"},{"key":"2020071613462292900_R31","doi-asserted-by":"crossref","first-page":"R1695","DOI":"10.1152\/ajpregu.00870.2004","article-title":"Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats","volume":"288","author":"Chelikani","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071613462292900_R32","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/en.2008-1221","article-title":"Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.","volume":"150","author":"Ru\u0308ttimann","year":"2009","journal-title":"Endocrinology"},{"key":"2020071613462292900_R33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","article-title":"The inhibitory effects of peripheral administration of peptide YY(3\u201336) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.","volume":"1044","author":"Abbott","year":"2005","journal-title":"Brain Res"},{"key":"2020071613462292900_R34","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1.","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"2020071613462292900_R35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2008.08.008","article-title":"Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.","volume":"8","author":"Troy","year":"2008","journal-title":"Cell Metab"},{"key":"2020071613462292900_R36","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1152\/ajpregu.00164.2007","article-title":"Intermittent intraperitoneal infusion of peptide YY(3\u201336) reduces daily food intake and adiposity in obese rats","volume":"293","author":"Chelikani","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2020071613462292900_R37","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral exendin-4 and peptide YY(3\u201336) synergistically reduce food intake through different mechanisms in mice.","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology"},{"key":"2020071613462292900_R38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2006.08.001","article-title":"Critical role for peptide YY in protein-mediated satiation and body-weight regulation.","volume":"4","author":"Batterham","year":"2006","journal-title":"Cell Metab"},{"key":"2020071613462292900_R39","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1210\/jc.2005-1357","article-title":"Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss.","volume":"90","author":"Roth","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613462292900_R40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/en.2005-0972","article-title":"Attenuated peptide YY release in obese subjects is associated with reduced satiety.","volume":"147","author":"Roux","year":"2006","journal-title":"Endocrinology"},{"key":"2020071613462292900_R41","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/ijo.2008.157","article-title":"Postprandial changes in gut regulatory peptides in gastric bypass patients.","volume":"32","author":"Holdstock","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"2020071613462292900_R42","doi-asserted-by":"crossref","first-page":"R1855","DOI":"10.1152\/ajpregu.00297.2007","article-title":"Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight","volume":"293","author":"Mack","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl 1","key":"2020071613462292900_R43","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ijo.2009.13","article-title":"Control of food intake and energy expenditure by amylin-therapeutic implications","volume":"33","author":"Lutz","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"2020071613462292900_R44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM200401153500323","article-title":"Fundus functionality and ghrelin concentrations after bariatric surgery.","volume":"350","author":"Fru\u0308hbeck","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071613462292900_R45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/oby.2003.126","article-title":"Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.","volume":"11","author":"Tritos","year":"2003","journal-title":"Obes Res"},{"key":"2020071613462292900_R46","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00464-004-8825-x","article-title":"Changes in serum ghrelin predict weight loss after Roux-en-Y gastric bypass in rats.","volume":"19","author":"Stylopoulos","year":"2005","journal-title":"Surg Endosc"},{"key":"2020071613462292900_R47","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1210\/jc.2002-021734","article-title":"Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans.","volume":"88","author":"Holdstock","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613462292900_R48","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ijo.2009.79","article-title":"Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.","volume":"33","author":"Korner","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"Suppl 1","key":"2020071613462292900_R49","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/ijo.2009.15","article-title":"Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery","volume":"33","author":"Cummings","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"2020071613462292900_R50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MED.0b013e3282f88a0a","article-title":"Gastrointestinal surgery as treatment for type 2 diabetes.","volume":"15","author":"Moo","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"Suppl 2","key":"2020071613462292900_R51","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.2337\/dc08-s271","article-title":"Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis","volume":"31","author":"Rubino","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/4\/1588\/9010686\/endo1588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/4\/1588\/9010686\/endo1588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T01:32:00Z","timestamp":1635039120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/4\/1588\/2456699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,23]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2009-1332","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,23]]}}}